SCHEMBL4334505

SCHEMBL4334505

CNP(=O)(OC)Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.55
L3MBTL1 Q9Y468 3/20 0.51
LMNA P02545 3/20 0.51
MEN1 O00255 8/20 0.50
KMT2A Q03164 8/20 0.50
HTT P42858 3/20 0.50
ALDH1A1 P00352 2/20 0.50
PKM P14618 1/20 0.50
HCRTR1 O43613 2/20 0.47
HPGD P15428 1/20 0.47
SRC P12931 1/20 0.47
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17322734 0.90 KDM4E (0.61) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL162660 0.81 MEN1 (0.56) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL20050181 0.78 MEN1 (0.49) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL5595049 0.77 MEN1 (0.51) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL9414571 0.76 KDM4E (0.65) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL25709661 0.74 BTN3A1 (0.53) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL132822 0.74 SRC (0.54) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL1725920 0.74 SRC (0.54) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL18831783 0.73 SRC (0.48) KDM4EL3MBTL1LMNAMEN1KMT2A
SCHEMBL28670802 0.73 MEN1 (0.60) KDM4EL3MBTL1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815834-B2 Use of dendrimers to stimulate cell growth CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-08-26 US disclosed
US-20090142316-A1 Use of Dendrimers to Stimulate Cell Growth CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-06-04 US disclosed
EP-1778252-A2 NONCARDIOTOXIC PHARMACEUTICAL COMPOUNDS Barbeau, Donald L. (US) 2007-05-02 EP disclosed
WO-2006020573-A2 NONCARDIOTOXIC PHARMACEUTICAL COMPOUNDS BARBEAU DONALD L (US) 2006-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090142316-A1 Use of Dendrimers to Stimulate Cell Growth HDGF, CD40LG, PPIP5K2 KDM4E 4303/4885L3MBTL1 4712/4885LMNA 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.